Memorial Sloan Kettering Cancer Center-Peds
1275 York Avenue
New York, NY 10065
Direct phone: (646) 608-2731
Total transplants by cell source
- Marrow: 23
- PBSC: 60
- Cord Blood: 9
- Autologous (PBSC or Marrow): 13
About the center
Physicians at Memorial Sloan-Kettering Cancer Center (MSKCC) have performed unrelated stem cell transplants since 1973. Many have also held leadership roles in the National Marrow Donor Program (NMDP) network, including chairperson of the Board and chairpersons of NMDP committees. Prior to 2010, the adult and pediatric transplant programs at MSKCC operated as a joint transplant program with combined reporting of data. The two programs are now independent NMDP transplant programs with separate outcomes reporting. The pediatric program data prior to 2010 can be accessed through the NMDP or by contacting MSKCC. Please see Memorial Sloan-Kettering Cancer Center - Adults for specific information regarding our adult BMT program.
This center has been performing allogeneic transplants since 1973 and has been an NMDP/Be The Match transplant center since February 1988.
Pediatric - Jaap J. Boelens, Farid Boulad, Maria Cancio, Kevin Curran, Nancy A. Kernan, Andrew Kung, Richard J. O Reilly, Susan Prockop, Andromachi Scaradavou, Barbara Spitzer
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
For a list of other programs and services available, please see our website: http://www.mskcc.org/pediatrics/why-choose-us
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 94 patients.
The actual 1-year survival of these patients is 91.5%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 78.1% and 92.1%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2017 to December 31st, 2018 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2017 to December 31st, 2018 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
If you have transplant-related questions, please call the transplant center's direct phone number.
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)